Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2011

01.12.2011 | Materno-Fetal Medicine

Effect of pre-pregnancy body mass index and weight gain during pregnancy on the risk of emergency cesarean section in nullipara

verfasst von: Dong Gyu Jang, Yun Sung Jo, Gui Se Ra Lee

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We attempted to examine the effects of delivery via emergency cesarean section in nullipara, presenting with increase in body weight during pregnancy and pre-pregnant body mass index.

Methods

A total of 1,024 nullipara with singleton pregnancy who experienced labor pain after 37 gestational weeks at St.Vincent’s Hospital of Catholic University of Korea during 1 January 2004 to 31 March 2010 were enrolled in this study. Study patients were divided into four groups based on pre-gestational BMI, two groups based on weight gain more than 18 kg during pregnancy and three groups based on weight gain according to the guidelines of IOM (Institute of Medicine). Univariate and multivariate analysis were performed.

Results

On univariate analysis, the frequency of emergency cesarean section was increased both in pre-pregnant overweight women and women with excess weight gain during pregnancy. On multivariate analysis, however, increase in body weight during pregnancy according to IOM guidelines did not independently affect the frequency of emergency cesarean section. If the degree of increase in body weight during pregnancy was divided based on a definite numeric value of 18 kg, the frequency of cesarean section was significantly increased.

Conclusions

For successful spontaneous delivery, the nullipara should become pregnant when the pre-gestational BMI is maintained at an appropriate level. We also propose that women should not gain more than 18 kg until delivery in all pre-BMI groups.
Literatur
1.
Zurück zum Zitat Rooney BL, Schauberger CW (2002) Excess pregnancy weight gain and long-term obesity: one decade later. Obstet Gynecol 100:245–252PubMedCrossRef Rooney BL, Schauberger CW (2002) Excess pregnancy weight gain and long-term obesity: one decade later. Obstet Gynecol 100:245–252PubMedCrossRef
2.
Zurück zum Zitat Young TK, Woodmansee B (2002) Factors that are associated with cesarean delivery in a large private practice: the importance of prepregnancy body mass index and weight gain. Am J Obstet Gynecol 187:312–318 discussion 318-320PubMedCrossRef Young TK, Woodmansee B (2002) Factors that are associated with cesarean delivery in a large private practice: the importance of prepregnancy body mass index and weight gain. Am J Obstet Gynecol 187:312–318 discussion 318-320PubMedCrossRef
3.
Zurück zum Zitat Phelan JP, Smith CV, Broussard P, Small M (1987) Amniotic fluid volume assessment with the four-quadrant technique at 36–42 weeks’ gestation. J Reprod Med 32:540–542PubMed Phelan JP, Smith CV, Broussard P, Small M (1987) Amniotic fluid volume assessment with the four-quadrant technique at 36–42 weeks’ gestation. J Reprod Med 32:540–542PubMed
4.
Zurück zum Zitat Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M (1996) A United States national reference for fetal growth. Obstet Gynecol 87:163–168PubMedCrossRef Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M (1996) A United States national reference for fetal growth. Obstet Gynecol 87:163–168PubMedCrossRef
5.
Zurück zum Zitat LaCoursiere DY, Bloebaum L, Duncan JD, Varner MW (2005) Population-based trends and correlates of maternal overweight and obesity, Utah 1991–2001. Am J Obstet Gynecol 192:832–839PubMedCrossRef LaCoursiere DY, Bloebaum L, Duncan JD, Varner MW (2005) Population-based trends and correlates of maternal overweight and obesity, Utah 1991–2001. Am J Obstet Gynecol 192:832–839PubMedCrossRef
6.
Zurück zum Zitat Helms E, Coulson CC, Galvin SL (2006) Trends in weight gain during pregnancy: a population study across 16 years in North Carolina. Am J Obstet Gynecol 194:e32–e34PubMedCrossRef Helms E, Coulson CC, Galvin SL (2006) Trends in weight gain during pregnancy: a population study across 16 years in North Carolina. Am J Obstet Gynecol 194:e32–e34PubMedCrossRef
7.
Zurück zum Zitat Rode L, Nilas L, Wojdemann K, Tabor A (2005) Obesity-related complications in Danish single cephalic term pregnancies. Obstet Gynecol 105:537–542PubMedCrossRef Rode L, Nilas L, Wojdemann K, Tabor A (2005) Obesity-related complications in Danish single cephalic term pregnancies. Obstet Gynecol 105:537–542PubMedCrossRef
8.
Zurück zum Zitat Cedergren MI (2004) Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 103:219–224PubMedCrossRef Cedergren MI (2004) Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 103:219–224PubMedCrossRef
9.
Zurück zum Zitat Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Carter SM, Craigo SD, Carr SR, D’Alton ME (2004) Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol 190:1091–1097PubMedCrossRef Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Carter SM, Craigo SD, Carr SR, D’Alton ME (2004) Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol 190:1091–1097PubMedCrossRef
10.
Zurück zum Zitat Doherty DA, Magann EF, Francis J, Morrison JC, Newnham JP (2006) Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 95:242–247PubMedCrossRef Doherty DA, Magann EF, Francis J, Morrison JC, Newnham JP (2006) Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 95:242–247PubMedCrossRef
11.
Zurück zum Zitat Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S (2001) Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord 25:1175–1182PubMedCrossRef Sebire NJ, Jolly M, Harris JP, Wadsworth J, Joffe M, Beard RW, Regan L, Robinson S (2001) Maternal obesity and pregnancy outcome: a study of 287, 213 pregnancies in London. Int J Obes Relat Metab Disord 25:1175–1182PubMedCrossRef
12.
Zurück zum Zitat Bodnar LM, Siega-Riz AM, Simhan HN, Himes KP, Abrams B (2010) Severe obesity, gestational weight gain, and adverse birth outcomes. Am J Clin Nutr 91:1642–1648PubMedCrossRef Bodnar LM, Siega-Riz AM, Simhan HN, Himes KP, Abrams B (2010) Severe obesity, gestational weight gain, and adverse birth outcomes. Am J Clin Nutr 91:1642–1648PubMedCrossRef
13.
Zurück zum Zitat Hillier TA, Pedula KL, Vesco KK, Schmidt MM, Mullen JA, LeBlanc ES, Pettitt DJ (2008) Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol 112:1007–1014PubMedCrossRef Hillier TA, Pedula KL, Vesco KK, Schmidt MM, Mullen JA, LeBlanc ES, Pettitt DJ (2008) Excess gestational weight gain: modifying fetal macrosomia risk associated with maternal glucose. Obstet Gynecol 112:1007–1014PubMedCrossRef
14.
Zurück zum Zitat Cedergren M (2006) Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 93:269–274PubMedCrossRef Cedergren M (2006) Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 93:269–274PubMedCrossRef
15.
Zurück zum Zitat Hedderson MM, Weiss NS, Sacks DA, Pettitt DJ, Selby JV, Quesenberry CP, Ferrara A (2006) Pregnancy weight gain and risk of neonatal complications: macrosomia, hypoglycemia, and hyperbilirubinemia. Obstet Gynecol 108:1153–1161PubMedCrossRef Hedderson MM, Weiss NS, Sacks DA, Pettitt DJ, Selby JV, Quesenberry CP, Ferrara A (2006) Pregnancy weight gain and risk of neonatal complications: macrosomia, hypoglycemia, and hyperbilirubinemia. Obstet Gynecol 108:1153–1161PubMedCrossRef
16.
Zurück zum Zitat Takimoto H, Sugiyama T, Fukuoka H, Kato N, Yoshiike N (2006) Maternal weight gain ranges for optimal fetal growth in Japanese women. Int J Gynaecol Obstet 92:272–278PubMedCrossRef Takimoto H, Sugiyama T, Fukuoka H, Kato N, Yoshiike N (2006) Maternal weight gain ranges for optimal fetal growth in Japanese women. Int J Gynaecol Obstet 92:272–278PubMedCrossRef
17.
Zurück zum Zitat Jain NJ, Denk CE, Kruse LK, Dandolu V (2007) Maternal obesity: can pregnancy weight gain modify risk of selected adverse pregnancy outcomes? Am J Perinatol 24:291–298PubMedCrossRef Jain NJ, Denk CE, Kruse LK, Dandolu V (2007) Maternal obesity: can pregnancy weight gain modify risk of selected adverse pregnancy outcomes? Am J Perinatol 24:291–298PubMedCrossRef
18.
Zurück zum Zitat Vahratian A, Siega-Riz AM, Savitz DA, Zhang J (2005) Maternal pre-pregnancy overweight and obesity and the risk of cesarean delivery in nulliparous women. Ann Epidemiol 15:467–474PubMedCrossRef Vahratian A, Siega-Riz AM, Savitz DA, Zhang J (2005) Maternal pre-pregnancy overweight and obesity and the risk of cesarean delivery in nulliparous women. Ann Epidemiol 15:467–474PubMedCrossRef
19.
Zurück zum Zitat Gareen IF, Morgenstern H, Greenland S, Gifford DS (2003) Explaining the association of maternal age with cesarean delivery for nulliparous and parous women. J Clin Epidemiol 56:1100–1110PubMedCrossRef Gareen IF, Morgenstern H, Greenland S, Gifford DS (2003) Explaining the association of maternal age with cesarean delivery for nulliparous and parous women. J Clin Epidemiol 56:1100–1110PubMedCrossRef
Metadaten
Titel
Effect of pre-pregnancy body mass index and weight gain during pregnancy on the risk of emergency cesarean section in nullipara
verfasst von
Dong Gyu Jang
Yun Sung Jo
Gui Se Ra Lee
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-1868-z

Weitere Artikel der Ausgabe 6/2011

Archives of Gynecology and Obstetrics 6/2011 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.